Influence of the BDNF Val66Met polymorphism on coping response to stress in patients with advanced gastric cancer

Min Jung Koh, Hei Cheul Jeung, Kee Namkoong, Hyuncheol Chung, Jee In Kang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Coping with cancer is an important determinant of psychological morbidity, quality of life, and treatment adherence in cancer patients. The aim of this study was to elucidate the association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and coping response to stress in patients diagnosed with advanced gastric cancer. Methods: Ninety-one subjects (60 males, 31 females) recently diagnosed with advanced gastric cancer were recruited. Coping style and distress level were examined using the Mini-Mental Adjustment to Cancer (Mini-MAC) scale and Hospital Anxiety and Depression Scale, and genotyping was evaluated. To examine the temporal stability of the Mini-MAC scores, a 6-week follow-up evaluation was conducted in 72 patients, after completion of two chemotherapy cycles. Results: Coping style to cancer significantly differed between the Met carriers of BDNF Val66Met and the Val/Val homozygotes. The Met carriers were significantly more anxious than the Val/Val homozygotes. Conclusion: The present findings suggest that the BDNF Val66Met polymorphism may be involved in individual coping responses to cancer. The Met allele of BDNF Val66Met may be predictive of an anxious coping style in patients with advanced cancer.

Original languageEnglish
Pages (from-to)76-80
Number of pages5
JournalJournal of Psychosomatic Research
Volume77
Issue number1
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Brain-Derived Neurotrophic Factor
Stomach Neoplasms
Social Adjustment
Neoplasms
Homozygote
Cancer Care Facilities
Anxiety
Alleles
Quality of Life
Depression
Psychology
Morbidity
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

@article{cd90de6d43c94552b1d3615f9f5b3631,
title = "Influence of the BDNF Val66Met polymorphism on coping response to stress in patients with advanced gastric cancer",
abstract = "Objective: Coping with cancer is an important determinant of psychological morbidity, quality of life, and treatment adherence in cancer patients. The aim of this study was to elucidate the association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and coping response to stress in patients diagnosed with advanced gastric cancer. Methods: Ninety-one subjects (60 males, 31 females) recently diagnosed with advanced gastric cancer were recruited. Coping style and distress level were examined using the Mini-Mental Adjustment to Cancer (Mini-MAC) scale and Hospital Anxiety and Depression Scale, and genotyping was evaluated. To examine the temporal stability of the Mini-MAC scores, a 6-week follow-up evaluation was conducted in 72 patients, after completion of two chemotherapy cycles. Results: Coping style to cancer significantly differed between the Met carriers of BDNF Val66Met and the Val/Val homozygotes. The Met carriers were significantly more anxious than the Val/Val homozygotes. Conclusion: The present findings suggest that the BDNF Val66Met polymorphism may be involved in individual coping responses to cancer. The Met allele of BDNF Val66Met may be predictive of an anxious coping style in patients with advanced cancer.",
author = "Koh, {Min Jung} and Jeung, {Hei Cheul} and Kee Namkoong and Hyuncheol Chung and Kang, {Jee In}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.jpsychores.2014.04.008",
language = "English",
volume = "77",
pages = "76--80",
journal = "Journal of Psychosomatic Research",
issn = "0022-3999",
publisher = "Elsevier Inc.",
number = "1",

}

Influence of the BDNF Val66Met polymorphism on coping response to stress in patients with advanced gastric cancer. / Koh, Min Jung; Jeung, Hei Cheul; Namkoong, Kee; Chung, Hyuncheol; Kang, Jee In.

In: Journal of Psychosomatic Research, Vol. 77, No. 1, 01.01.2014, p. 76-80.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Influence of the BDNF Val66Met polymorphism on coping response to stress in patients with advanced gastric cancer

AU - Koh, Min Jung

AU - Jeung, Hei Cheul

AU - Namkoong, Kee

AU - Chung, Hyuncheol

AU - Kang, Jee In

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objective: Coping with cancer is an important determinant of psychological morbidity, quality of life, and treatment adherence in cancer patients. The aim of this study was to elucidate the association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and coping response to stress in patients diagnosed with advanced gastric cancer. Methods: Ninety-one subjects (60 males, 31 females) recently diagnosed with advanced gastric cancer were recruited. Coping style and distress level were examined using the Mini-Mental Adjustment to Cancer (Mini-MAC) scale and Hospital Anxiety and Depression Scale, and genotyping was evaluated. To examine the temporal stability of the Mini-MAC scores, a 6-week follow-up evaluation was conducted in 72 patients, after completion of two chemotherapy cycles. Results: Coping style to cancer significantly differed between the Met carriers of BDNF Val66Met and the Val/Val homozygotes. The Met carriers were significantly more anxious than the Val/Val homozygotes. Conclusion: The present findings suggest that the BDNF Val66Met polymorphism may be involved in individual coping responses to cancer. The Met allele of BDNF Val66Met may be predictive of an anxious coping style in patients with advanced cancer.

AB - Objective: Coping with cancer is an important determinant of psychological morbidity, quality of life, and treatment adherence in cancer patients. The aim of this study was to elucidate the association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and coping response to stress in patients diagnosed with advanced gastric cancer. Methods: Ninety-one subjects (60 males, 31 females) recently diagnosed with advanced gastric cancer were recruited. Coping style and distress level were examined using the Mini-Mental Adjustment to Cancer (Mini-MAC) scale and Hospital Anxiety and Depression Scale, and genotyping was evaluated. To examine the temporal stability of the Mini-MAC scores, a 6-week follow-up evaluation was conducted in 72 patients, after completion of two chemotherapy cycles. Results: Coping style to cancer significantly differed between the Met carriers of BDNF Val66Met and the Val/Val homozygotes. The Met carriers were significantly more anxious than the Val/Val homozygotes. Conclusion: The present findings suggest that the BDNF Val66Met polymorphism may be involved in individual coping responses to cancer. The Met allele of BDNF Val66Met may be predictive of an anxious coping style in patients with advanced cancer.

UR - http://www.scopus.com/inward/record.url?scp=84901988801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901988801&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychores.2014.04.008

DO - 10.1016/j.jpsychores.2014.04.008

M3 - Article

VL - 77

SP - 76

EP - 80

JO - Journal of Psychosomatic Research

JF - Journal of Psychosomatic Research

SN - 0022-3999

IS - 1

ER -